Correlation Between Brainsway and Abattis Bioceuticals
Can any of the company-specific risk be diversified away by investing in both Brainsway and Abattis Bioceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Brainsway and Abattis Bioceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Brainsway and Abattis Bioceuticals Corp, you can compare the effects of market volatilities on Brainsway and Abattis Bioceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Brainsway with a short position of Abattis Bioceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Brainsway and Abattis Bioceuticals.
Diversification Opportunities for Brainsway and Abattis Bioceuticals
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Brainsway and Abattis is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Brainsway and Abattis Bioceuticals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abattis Bioceuticals Corp and Brainsway is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Brainsway are associated (or correlated) with Abattis Bioceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abattis Bioceuticals Corp has no effect on the direction of Brainsway i.e., Brainsway and Abattis Bioceuticals go up and down completely randomly.
Pair Corralation between Brainsway and Abattis Bioceuticals
Given the investment horizon of 90 days Brainsway is expected to generate 9.04 times less return on investment than Abattis Bioceuticals. But when comparing it to its historical volatility, Brainsway is 15.26 times less risky than Abattis Bioceuticals. It trades about 0.1 of its potential returns per unit of risk. Abattis Bioceuticals Corp is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest 0.00 in Abattis Bioceuticals Corp on September 3, 2024 and sell it today you would earn a total of 0.01 from holding Abattis Bioceuticals Corp or generate 9.223372036854776E16% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Brainsway vs. Abattis Bioceuticals Corp
Performance |
| Timeline |
| Brainsway |
| Abattis Bioceuticals Corp |
Brainsway and Abattis Bioceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Brainsway and Abattis Bioceuticals
The main advantage of trading using opposite Brainsway and Abattis Bioceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Brainsway position performs unexpectedly, Abattis Bioceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abattis Bioceuticals will offset losses from the drop in Abattis Bioceuticals' long position.| Brainsway vs. Tandem Diabetes Care | Brainsway vs. Inspire Medical Systems | Brainsway vs. Penumbra | Brainsway vs. Insulet |
| Abattis Bioceuticals vs. Amexdrug | Abattis Bioceuticals vs. Aion Therapeutic | Abattis Bioceuticals vs. Antisense Therapeutics Limited | Abattis Bioceuticals vs. Alterola Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |